Corebridge Financial’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,191
Closed -$748K 255
2025
Q1
$748K Sell
23,191
-344
-1% -$12.8K ﹤0.01% 1394
2024
Q4
$719K Sell
23,535
-1,776
-7% -$57.1K ﹤0.01% 1488
2024
Q3
$710K Sell
25,311
-157
-0.6% -$3.87K ﹤0.01% 1542
2024
Q2
$580K Buy
+25,468
New +$588K ﹤0.01% 1610

Other funds holding ATRC

Corebridge Financial's ATRC Position: Q2 2025 in Review

Corebridge Financial sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 23,191 shares — an estimated $748K sold.

Corebridge Financial first reported a position in ATRC in Q2 2024 and held it in 4 quarters. The position peaked at $748K in Q1 2025. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • Corebridge Financial reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 23,191 AtriCure shares in Q2 2025, an estimated $748K.
  • Corebridge Financial first reported a position in AtriCure in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's AtriCure position peaked at $748K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.